OPD cover in health insurance addresses out-of-pocket expenses for doctor visits, diagnostics, and medicines without hospitalization. While...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...

In a significant policyholder-centric move, IRDAI has linked insurance executive pay to customer-centric metrics like claim settlement and ...

New health plans cover treatments requiring two hours of hospitalisation, but exclusions remain critical.

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

A Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the St...

President Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

In the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...

India's healthcare is changing. Value is moving from hospitals to patients' daily lives. A new 'phydigital' model combines physical and dig...

For the last five years, the theme on the street has mostly been: Buy today, expect comfort tomorrow. But some of the better wealth-creatin...

The Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...

Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...

Medical coverage, duration and geography, add-ons, and claims experience are some aspects one must keep in mind before selecting the intern...

Health insurance premiums in India are rising by up to 25% due to escalating healthcare costs, increased claims, and changing risk profiles...

India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...

Mankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...